Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Research & Development (2020 - 2025)

Historic Research & Development for Silo Pharma (SILO) over the last 6 years, with Q3 2025 value amounting to $543615.0.

  • Silo Pharma's Research & Development rose 503.66% to $543615.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 8718.61%. This contributed to the annual value of $2.4 million for FY2024, which is 18022.46% up from last year.
  • Per Silo Pharma's latest filing, its Research & Development stood at $543615.0 for Q3 2025, which was up 503.66% from $717247.0 recorded in Q2 2025.
  • Silo Pharma's Research & Development's 5-year high stood at $1.1 million during Q4 2024, with a 5-year trough of $48602.0 in Q1 2021.
  • Its 5-year average for Research & Development is $367610.1, with a median of $336965.0 in 2023.
  • Per our database at Business Quant, Silo Pharma's Research & Development surged by 746860.64% in 2021 and then tumbled by 5356.64% in 2023.
  • Quarter analysis of 5 years shows Silo Pharma's Research & Development stood at $475948.0 in 2021, then skyrocketed by 33.35% to $634684.0 in 2022, then crashed by 46.91% to $336965.0 in 2023, then surged by 219.24% to $1.1 million in 2024, then crashed by 49.46% to $543615.0 in 2025.
  • Its Research & Development stands at $543615.0 for Q3 2025, versus $717247.0 for Q2 2025 and $593962.0 for Q1 2025.